Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Ranking of the most effective treatments for cardiovascular disease using SUCRA: Is it as sweet as it appears?
Carter, Rickey E. , Carter, Rickey E , Wang, Zhen

Mayo Clinic

European Journal of Preventive Cardiology | March 23, 2018 | Volume: 25 | Issue: 8 | Pages: 842-843

10.1177/2047487318767199 | PMID 29569939 Get It

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
Vidal, Claudia I. , Armbrect, Eric A., Andea, Aleodor A. , Bohlke, Angela, Comfere, Nneka I. , Hughes, Sarah , Kim, Jinah , Kozel, Jessica A. , Lee, Jason B. , Linos, Konstantinos , Litzner, Brandon R. , Missall, Tricia A. , Sundram, Uma , Swick, Brian L. , Hurley, M. Yadira , Alam, Murad , Argényi, Zsolt B., Duncan, Lyn M., Elston, Dirk M. , Emanuel, Patrick O. , Ferringer, Tammie , Fung, Maxwell A. , Hosler, Gregory A. , Lazar, Alexander J. , Prieto, Víctor G. , Schaffer, András , Subtil, Antonio , Wang, Wei‐Lien , Sundram, Uma , Hurley, Maria Yadira , Emanuel, Patrick O , Fung, Maxwell A , Hosler, Gregory A , Lazar, Alexander J , Vidal, Claudia I , Kim, Jinah , Linos, Konstantinos , Missall, Tricia A , Novoa, Roberto A. , Alam, Murad , Lowe, Lori , Plaza, Jose Antonio , Robinson, June K.

Mayo Clinic

Journal of Cutaneous Pathology | March 22, 2018 | Volume: 45 | Issue: 8 | Pages: 563-580

10.1111/cup.13142 | PMID 29566273 Get It

BackgroundAppropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision‐making.ObjectivesThe American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology.MethodsThe RAND/UCLA appropriateness methodology, which combines evidence‐based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology.ResultsWith the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”LimitationsThe methodology requires a focus on appropriateness without comparison between tests and irrespective of cost.ConclusionsThe ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.
Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells
Wang, Yinfang, Liu, Youbin , Li, Jin‐Ping , Hao, Yilong, Yin, Peihao , Liu, Zongjun , Chen, Jingzhou , Wang, Ying , Wang, Nanping , Zhang, Peng , Wang, Yinfang, Huang, Yitong Pepper , Wang, Ying

Mayo Clinic

The FASEB Journal | March 20, 2018 | Volume: 32 | Issue: 8 | Pages: 4504-4518

10.1096/fj.201701143rr | PMID 29558204 Get It

Mitochondria are dynamic organelles that are able to change their morphology and cellular distribution by either fission or fusion. However, the molecular mechanisms controlling mitochondrial dynamics in vascular endothelial cells (ECs) remain largely unknown. In this study, we observed that knockdown of microtubule‐associated tumor suppressor 1 (MTUS1) in ECs inhibited tube formation and migration, accompanied with decreased promigratory signalings. We showed that MTUS1 was localized in the outer membrane of mitochondria in ECs. Knockdown of MTUS1 disturbed the elongated mitochondrial network and induced the formation of perinuclear clusters of mitochondria. Importantly, mitochondrial motility and fusion were suppressed, whereas generation of reactive oxygen species was increased in MTUS1 knockdown ECs. Mechanistically, we showed that the N‐terminal coiled‐coil domain of MTUS1 interacted with the mitochondrial membrane proteins, mitofusin‐1 and mitofusin‐2, to maintain mitochondrial morphology in ECs. This study illustrated a novel role of MTUS1 in mitochondrial morphology and EC angiogenic responses.—Wang Y., Huang Y., Liu, Y., Li, J., Hao, Y., Yin, P., Liu, Z., Chen J., Wang Y., Wang N., Zhang P., Microtubule associated tumor suppressor 1 interacts with mitofusins to regulate mitochondrial morphology in endothelial cells. FASEB J . 32, 4504–4518 (2018). www.fasebj.org
Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma
Wei, Xiaomu , Calvo-Vidal, M. Nieves, Chen, Siwei , Wu, Gang , Revuelta, María V. , Zhang, Jinghui , Walsh, Michael F. , Nichols, Kim E. , Vijai, Joseph , Snyder, Carrie, Vachon, Celine M. , McKay, James , Wang, Shuping , Jayabalan, David , Jacobs, Lauren , Becirovic, Dina, Waller, Rosalie G., Artomov, Mykyta , Viale, Agnès , Patel, Jayeshkumar , Curtin, Karen , Salama, Mohamed E. , Atanackovic, Djordje , Niesvizky, Rubén, Godley, Lucy A. , Churpek, Jane E. , Dumontet, Charles , Lynch, Henry T., Camp, Nicola J. , Offit, Kenneth , Klein, Robert J. , Lipkin, Steven M. , Waller, Rosalie G. , Griffin, R. L. , Joseph, Vijai , Revuelta, Maria , Waller, Rosalie G , Godley, Lucy A , Sun, Jian Hua , Vachon, Celine M. , Waller, Rosalie G., Phillip, Jude M. , Chen‐Kiang, Selina , Landgren, Ola , Slager, Susan L. , Garber, Judy E. , Anderson, Kenneth C. , Daly, Mark J. , Roeder, Robert G. , Mullighan, Charles G. , Yu, Haiyuan , Cerchietti, Leandro C. A. , Wu, Gang , Nichols, Kim E , Griffin, Rosalie , Klein, Robert , Churpek, Jane E , Churpek, Jane

Mayo Clinic

Cancer Research | March 20, 2018 | Volume: 78 | Issue: 10 | Pages: 2747-2759

10.1158/0008-5472.can-17-1900 | PMID 29559475 Get It

Abstract Given the frequent and largely incurable occurrence of multiple myeloma, identification of germline genetic mutations that predispose cells to multiple myeloma may provide insight into disease etiology and the developmental mechanisms of its cell of origin, the plasma cell (PC). Here, we identified familial and early-onset multiple myeloma kindreds with truncating mutations in lysine-specific demethylase 1 (LSD1/KDM1A), an epigenetic transcriptional repressor that primarily demethylates histone H3 on lysine 4 and regulates hematopoietic stem cell self-renewal. In addition, we found higher rates of germline truncating and predicted deleterious missense KDM1A mutations in patients with multiple myeloma unselected for family history compared with controls. Both monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma cells have significantly lower KDM1A transcript levels compared with normal PCs. Transcriptome analysis of multiple myeloma cells from KDM1A mutation carriers shows enrichment of pathways and MYC target genes previously associated with myeloma pathogenesis. In mice, antigen challenge followed by pharmacologic inhibition of KDM1A promoted PC expansion, enhanced secondary immune response, elicited appearance of serum paraprotein, and mediated upregulation of MYC transcriptional targets. These changes are consistent with the development of MGUS. Collectively, our findings show that KDM1A is the first autosomal-dominant multiple myeloma germline predisposition gene providing new insights into its mechanistic roles as a tumor suppressor during post-germinal center B-cell differentiation. Significance: KDM1A is the first germline autosomal dominant predisposition gene identified in multiple myeloma and provides new insights into multiple myeloma etiology and the mechanistic role of KDM1A as a tumor suppressor during post-germinal center B-cell differentiation. Cancer Res; 78(10); 2747–59. ©2018 AACR.
Prognostic factors for human papillomavirus–positive and negative oropharyngeal carcinomas
Yin, Linda X. , DʼSouza, Gypsyamber , Westra, William H. , Wang, Steven J. , Zante, Annemieke van , Zhang, Yuehan , Rettig, Eleni M. , Ryan, William R. , Ha, Patrick K. , Wentz, Alicia, Koch, Wayne M. , Eisele, David W. , Fakhry, Carole , Koch, Wayne , Yin, Linda X

Mayo Clinic

The Laryngoscope | March 15, 2018 | Volume: 128 | Issue: 8 | Pages: No page available

10.1002/lary.27130 | PMID 29536542 Get It

Objectives/HypothesisHuman papillomavirus (HPV)‐positive and HPV‐negative oropharyngeal squamous cell carcinoma (OPSCC) are distinct disease entities. Prognostic factors specific to each entity have not been adequately explored. Goals for this study were: 1) to determine whether HPV‐positive and HPV‐negative OPSCCs have distinct prognostic factors, and 2) to explore the prognostic significance of sex and race in OPSCC after HPV stratificationStudy DesignRetrospective case series.MethodsA retrospective review of 239 incident OPSCC patients from 1995 to 2012, treated at Johns Hopkins and University of California–San Francisco was conducted. Women and nonwhite races were oversampled. All analyses were stratified by tumor HPV in situ hybridization status. The effects of sex and race on survival were considered in Kaplan‐Meier and unadjusted and adjusted Cox regression models.ResultsOne hundred thirty‐four (56.1%) OPSCC patients were HPV positive. On univariate analysis, women had better overall survival than men among HPV‐positive (hazard ratio [HR]: 0.47, 95% confidence interval [CI]: 0.20‐1.07; P = .06) but not HPV‐negative (HR: 0.73, 95% CI: 0.43‐1.24; P = .24) OPSCCs. On multivariate analysis, women with HPV‐positive OPSCCs remained at lower risk of death (adjusted hazard ratio [aHR]: 0.34, 95% CI: 0.12‐0.96; P = .04). Survival did not vary significantly by race among HPV‐positive patients. Among HPV‐negative patients, Hispanic patients had significantly better survival in unadjusted (HR: 0.27, 95% CI: 0.08‐0.91; P = .04) but not adjusted (aHR: 0.93, 95% CI: 0.11‐7.36; P = .94) analysis.ConclusionsWomen with HPV‐positive OPSCC may have improved overall survival compared to men. Sex does not play a prognostic role in HPV‐negative OPSCC. There are no differences in prognosis by race among HPV‐positive or HPV‐negative patients.Level of Evidence4 Laryngoscope, E288–E296, 2018
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice
Li, Shuang , Robinson, Jennifer G. , Roger, Véronique L. , Goldberg, Anne C. , Wilson, Peter W.F. , Lee, L. Veronica, Elassal, Joseph, Wang, Tracy Y., Virani, Salim, Návar, Ann Marie , Peterson, Eric D. , Virani, Salim S. , Nanna, Michael G.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 15, 2018 | Volume: 11 | Issue: 3 | Pages: No page available

10.1161/circoutcomes.117.004249 | PMID 29545393 Get It

Predicted Arabidopsis Interactome Resource and Gene Set Linkage Analysis: A Transcriptomic Analysis Resource
Yao, Heng , Wang, Xiaoxuan , Chen, Pengcheng , Jin, Kang , Yao, Lixia , Mao, Chuanzao , Chen, Xin , Jin, Kang , Yao, Lixia , Mao, Chuanzao , Chen, Xin , Hai, Ling

Mayo Clinic

Plant Physiology | March 12, 2018 | Volume: 177 | Issue: 1 | Pages: 422-433

10.1104/pp.18.00144 | PMID 29530937 Get It

Association of sporadic and familial Barrett's esophagus with breast cancer
Chan, Megan , Blum, Andrew E., Chandar, Apoorva K., Emmons, Agnieszka, Shindo, Yuri, Brock, Wendy , Wang, J S, Iyer, Prasad G. , Shaheen, Nicholas J. , Thota, Prashanthi N. , Guda, Kishore , Chak, Amitabh , Falk, Gary W. , Canto, Marcia Irene , Grady, William M. , Abrams, Julian A

Mayo Clinic

Diseases of the Esophagus | March 8, 2018 | Volume: 31 | Issue: 4 | Pages: No page available

10.1093/dote/doy007 | PMID 29528378 Get It

Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
Barrionuevo, Patricia , Nabhan, Mohammed , Altayar, Osama , Erwin, Patricia J., Asi, Noor, Martin, Kathryn A. , Murad, M. Hassan , Murad, M Hassan , Wang, Zhen , Altayar, Osama

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 7, 2018 | Volume: 103 | Issue: 4 | Pages: 1258-1264

10.1210/jc.2017-02052 | PMID 29522176 Get It